Peter Gilling

A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria

P.J. O’Sullivan, Katrina Sharples, Mark E. Dalphin et al. · The Journal of Urology · 2012 · 168 citations

Medicine, Oncology, Urology +14

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Fred Saad, Egils Vjaters, Neal D. Shore et al. · Journal of Clinical Oncology · 2024 · 141 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma

L. Kavalieris, P.J. O’Sullivan, James M. Suttie et al. · BMC Urology · 2015 · 46 citations · Full text

Medicine, Oncology, Urology +17

Treatment modalities for Māori and New Zealand European men with localised prostate cancer

Zuzana Obertová, Ross Lawrenson, Nina Scott et al. · International Journal of Clinical Oncology · 2015 · 13 citations

Medicine, Oncology, Urology +14

Screening for prostate cancer in New Zealand general practice

Zuzana Obertová, Lawrenson Ross, Fraser Hodgson et al. · Journal of Medical Screening · 2013 · 11 citations · Full text

Medicine, Oncology, Urology +14